Literature DB >> 12430908

Beta-thalassaemia prototype of a single gene disorder with multiple phenotypes.

Swee Lay Thein1.   

Abstract

As the defective genes for more and more genetic disorders become unravelled, it is clear that patients with the same genotype can have many different clinical conditions even in monogenic disorders. The remarkable phenotypic diversity of the beta thalassaemias is prototypical of how the wide spectrum in disease severity can be generated. The most reliable and predictive factor of disease phenotype is the nature of the mutation at the beta-globin locus itself. However, relating phenotype to genotype is complicated by the complex interaction of the environment and other genetic factors at the secondary and tertiary levels, some implicated, and others, as yet unidentified. This article reviews the clinical and haematological diversity encountered in beta thalassaemia and their relationship with the underlying genotypes.

Entities:  

Mesh:

Year:  2002        PMID: 12430908     DOI: 10.1007/bf03165097

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  38 in total

Review 1.  Is it dominantly inherited beta thalassaemia or just a beta-chain variant that is highly unstable?

Authors:  S L Thein
Journal:  Br J Haematol       Date:  1999-10       Impact factor: 6.998

Review 2.  Quality control of mRNA function.

Authors:  L E Maquat; G G Carmichael
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

3.  Global prevalence of putative haemochromatosis mutations.

Authors:  A T Merryweather-Clarke; J J Pointon; J D Shearman; K J Robson
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

4.  Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2.

Authors:  G J Dover; K D Smith; Y C Chang; S Purvis; A Mays; D A Meyers; C Sheils; G Serjeant
Journal:  Blood       Date:  1992-08-01       Impact factor: 22.113

5.  A novel mechanism for thalassaemia intermedia.

Authors:  C Badens; M G Mattei; A M Imbert; C Lapouméroulie; N Martini; G Michel; D Lena-Russo
Journal:  Lancet       Date:  2002-01-12       Impact factor: 79.321

6.  The molecular basis of thalassaemia major and thalassaemia intermedia in Asian Indians: application to prenatal diagnosis.

Authors:  S L Thein; C Hesketh; R B Wallace; D J Weatherall
Journal:  Br J Haematol       Date:  1988-10       Impact factor: 6.998

7.  Molecular analysis of beta zero-thalassemia intermedia in Sardinia.

Authors:  R Galanello; E Dessi; M A Melis; M Addis; M A Sanna; C Rosatelli; F Argiolu; N Giagu; M P Turco; E Cacace
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

8.  Bone mineral metabolism in adults with beta-thalassaemia major and intermedia.

Authors:  R Dresner Pollack; E Rachmilewitz; A Blumenfeld; M Idelson; A W Goldfarb
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

9.  Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia.

Authors:  E Economou-Petersen; A Aessopos; A Kladi; P Flevari; F Karabatsos; C Fragodimitri; P Nicolaidis; H Vrettou; D Vassilopoulos; M Karagiorga-Lagana; D T Kremastinos; M B Petersen
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

10.  Genetic interactions in thalassemia intermedia: analysis of beta-mutations, alpha-genotype, gamma-promoters, and beta-LCR hypersensitive sites 2 and 4 in Italian patients.

Authors:  C Camaschella; U Mazza; A Roetto; E Gottardi; A Parziale; M Travi; S Fattore; D Bacchiega; G Fiorelli; M D Cappellini
Journal:  Am J Hematol       Date:  1995-02       Impact factor: 10.047

View more
  3 in total

1.  A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.

Authors:  Cristina Zuccato; Laura Breda; Francesca Salvatori; Giulia Breveglieri; Sara Gardenghi; Nicoletta Bianchi; Eleonora Brognara; Ilaria Lampronti; Monica Borgatti; Stefano Rivella; Roberto Gambari
Journal:  Ann Hematol       Date:  2012-03-31       Impact factor: 3.673

2.  Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.

Authors:  Nicoletta Bianchi; Cristina Zuccato; Ilaria Lampronti; Monica Borgatti; Roberto Gambari
Journal:  Evid Based Complement Alternat Med       Date:  2007-12-11       Impact factor: 2.629

3.  Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.

Authors:  Giulia Breveglieri; Irene Mancini; Nicoletta Bianchi; Ilaria Lampronti; Francesca Salvatori; Enrica Fabbri; Cristina Zuccato; Lucia C Cosenza; Giulia Montagner; Monica Borgatti; Fiorella Altruda; Sharmila Fagoonee; Gianni Carandina; Michele Rubini; Vincenzo Aiello; Laura Breda; Stefano Rivella; Roberto Gambari; Alessia Finotti
Journal:  Biomed Res Int       Date:  2015-05-04       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.